How Trimoryn Works: Three Routes in One Capsule

Konjac extract fibre at 50 mg is standardised to 90% glucomannan. Glucomannan is a soluble, highly viscous fibre from the root of the konjac plant, and its whole behaviour follows from one property: it takes up many times its own weight in water and thickens what it is in. In the stomach that slows gastric emptying; further down it thickens intestinal contents and slows absorption.

A randomised cross-over trial in sixteen healthy adults tested the appetite side directly by replacing a high-carbohydrate preload with volume-matched konjac glucomannan gel noodles. Cumulative energy intake fell by up to 47% and people did not eat more at the following meal to make it up, so the energy deficit held. Hunger ratings rose on the largest substitution, which is the honest caveat: fullness and low energy intake are not the same thing.

A meta-analysis of fourteen trials in 531 people found glucomannan lowered total cholesterol by 19.3 mg/dL, LDL cholesterol by 16.0 mg/dL, triglycerides, fasting blood glucose and body weight by 0.79 kg. A comprehensive review of 136 human fibre studies is the wider and more sceptical view: most extracted fibres do not move appetite ratings at all, and viscosity is what separates the ones that do from the ones that do not.

The amount here is 45 mg of glucomannan a day and the trials used grams. The dosage section prints that comparison in full rather than leaving it to be inferred.

Akkermansia muciniphila lives in the mucus layer lining the gut and feeds on it, and its abundance is inversely associated with obesity, untreated type 2 diabetes and hypertension in observational work. A proof-of-concept exploratory study published in Nature Medicine took that association into a trial: 32 overweight, insulin-resistant volunteers completed three months of daily supplementation at 10 billion bacteria. The pasteurised form improved insulin sensitivity by 28.6%, reduced insulinaemia by 34.1% and lowered total cholesterol by 8.7%; body weight and fat mass moved slightly and did not reach significance. The study's own primary endpoints were safety and tolerability.

Bifidobacterium breve is the older and better-mapped of the two. A twelve-week randomised, double-blind, placebo-controlled trial in 80 pre-obese adults used the B-3 strain at 20 billion colony forming units a day and found body fat mass and percent body fat lower in the probiotic group at weeks eight and twelve. A meta-analysis of 200 probiotic and synbiotic trials in 12,603 adults gives the category-level picture: small but consistent reductions in body weight, body mass index, waist circumference and fat mass.

Two things the panel does not say. It does not give a strain designation for either species, so whether the B. breve here is B-3 is not stated. And it gives a billion colony forming units each, where the two trials above used ten and twenty. NCCIH and the NIH fact sheet on probiotics are both clear that effects are strain-specific and dose-dependent, which is exactly why those two omissions matter.

• No caffeine and no stimulant of any kind. No green tea extract, no capsaicin, no synephrine, no guarana. The seller says the formula works without harsh stimulants and the panel agrees with it.
• No piperine. Which matters for exactly one entry: curcumin absorption is poor without it, and there is none here.
• No proprietary blend. Eleven names, eleven amounts, no group total to guess behind.
• No garcinia, no apple cider vinegar and no green coffee bean extract, which are three things a reader arriving from this aisle most often expects and which this panel does not carry. Green coffee beans do appear in the seller’s product photography, which is worth knowing before reading them as an ingredient.